Addition of triamcinolone to viscosupplementation improves short-term pain and function .
This report has been verified
by one or more authors of the
original publication.
Adding triamcinolone improves viscosupplementation: a randomized clinical trial
Clin Orthop Relat Res. 2013 Feb;471(2):613-20. doi: 10.1007/s11999-012-2659-y. Epub 2012 Oct 26104 patients with knee osteoarthritis were randomized to examine whether the addition of triamcinolone to viscosupplementation would improve pain and function in the short- (1 week) and long-term (24 weeks) in comparison to viscosupplementation alone. Patients received either a single injection (6 mL) of hylan GF-20 or a single injection of hylan GF-20 (6 mL) with 1 mL of triamcinolone hexacetonide. The assessment at 24 weeks revealed that the addition of triamcinolone improved pain and function in the first week, but displayed no improvements thereafter.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
